| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Bruce J McCreedy Jr. last filed a Form 4 in February 2024, as Director at DCOY. Bruce J McCreedy Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,788 shares of DCOY. Net of sales, the DCOY filings show accumulation of 8,700 shares.
Bruce J McCreedy Jr. has 8 Form 4 filings on record from September 2019 to February 2024, all as Director at Salarius Pharmaceuticals (DCOY), 2019–2024.
The 8 reported transactions were 5 option or other derivative awards, 2 open-market purchases and 1 stock award.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and no sales.
The only open-market purchase was 8,700 shares of DCOY at an average $1.15 on February 11, 2020, about $10K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2020 | DCOY Salarius Pharmaceuticals, Inc. | Director | Buy | 8,700 | $1.15 | $10,005.00 | New |